Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma

FORTE trial results: KRd with or without transplantation in newly diagnosed myeloma according to risk status

Carfilzomib and irinotecan in relapsed small cell lung cancer

Proton therapy or photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer

Olaparib and durvalumab in metastatic BRCA wild type triple-negative breast cancer

CASSIOPEIA: Daratumumab plus D-VTd vs VTd in transplant-eligible NDMM

ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcomas

Clinical activity and tolerability of the RET inhibitor BLUE-667 in patients with advanced RET fusion and NSCLC

ZUMA-3: A study of KTE-X19 in adults with relapsed/refractory acute lymphoblastic leukaemia

Better education about breast cancer treatment in Africa

A severe lack of cancer care in Burundi

Predictive models for treatment risk in cancer